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antibody response
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Department of Microbiology and Immunology, School of Medicine, The University of Texas Health Science Center,  
San Antonio, TX, USA
B cells are central to adaptive immunity and their functions in antibody responses are 
exquisitely regulated. As suggested by recent findings, B cell differentiation is mediated 
by intracellular membrane structures (including endosomes, lysosomes, and autopha-
gosomes) and protein factors specifically associated with these membranes, including 
Rab7, Atg5, and Atg7. These factors participate in vesicle formation/trafficking, signal 
transduction and induction of gene expression to promote antigen presentation, class 
switch DNA recombination (CSR)/somatic hypermutation (SHM), and generation/main-
tenance of plasma cells and memory B cells. Their expression is induced in B cells acti-
vated to differentiate and further fine-tuned by immune-modulating microRNAs, which 
coordinates CSR/SHM, plasma cell differentiation, and memory B cell differentiation. 
These short non-coding RNAs would individually target multiple factors associated with 
the same intracellular membrane compartments and collaboratively target a single factor 
in addition to regulating AID and Blimp-1. These, together with regulation of microRNA 
biogenesis and activities by endosomes and autophagosomes, show that intracellular 
membranes and microRNAs, two broadly relevant cell constituents, play important 
roles in balancing gene expression to specify B cell differentiation processes for optimal 
antibody responses.
Keywords: B cell activation and differentiation, plasma cell, memory B cell, intracellular membrane associated 
proteins, endosome, lysosome, autophagosome, microRNA
Abbreviations: Ago, argonaute; AID, activation-induced cytidine deaminase; Atg, autophagy-related gene; BCR, B cell recep-
tor; Blimp-1, B lymphocyte-induced maturation protein-1; CSR, class switch DNA recombination; ER, endoplasmic reticulum; 
GAP, GTPase activating protein; HDI, histone deacetylase inhibitors; Ig, immunoglobulin; KO, knockout; MHC II, major 
histocompatibility complex II; PI-3K, class III phosphatidylinositol 3-kinase; RA, rheumatoid arthritis; Rab, Ras-related in 
brain; RISC, RNA-induced silencing complex; SHM, somatic hypermutation; TCR, T cell receptor; TLR, toll-like receptor; 
VPS, vacuolar protein sorting.
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iNTRODUCTiON
B lymphocytes are critical to immunity by mediating production 
of neutralization antibodies to infectious pathogens and tumor 
cells (1). They develop through several highly regulated steps, first 
as pro-B cells and then pre-B cells in the bone marrow, in which 
immunoglobulin (Ig) V(D)J DNA recombination occurs, and 
subsequently as immature B cell stages and then mature B cells in 
the periphery. V(D)J recombination gives rise to a highly diverse 
repertoire of the B cell receptor (BCR) for antigens. Unlike imma-
ture B cells, which express predominantly IgM-containing BCRs, 
mature naïve B cells express high levels of IgD on their surface. 
In secondary lymphoid organs (e.g., spleen and lymph nodes), B 
cells are organized into the follicular or marginal zone areas (2), 
in part due to their BCR signaling differences.
Upon antigen encounter, B cells are activated in a T cell-inde-
pendent or T cell-dependent manner. In T-independent antibody 
responses and the early T-independent phase of T-dependent 
antibody responses, B cells differentiate upon dual engagement of 
BCR (e.g., by repetitive antigenic ligands) and an innate immune 
receptor, such as a toll-like receptor (TLR) (3). In T-dependent 
antibody responses, specific B cells are induced through cognate 
interaction, and engagement of CD40, which is constitutively 
expressed on B cells, by trimeric CD154 expressed by specific T 
helper (TH) cells (4). Activated B cells differentiate in germinal 
centers, the newly formed specialized microenvironment within 
secondary lymphoid organs (5). They undergo class switch DNA 
recombination (CSR) in the Ig heavy chain (IgH) locus to switch 
their BCR from IgM or IgD to, depending on eliciting stimuli, IgG, 
IgE, or IgA, which endows an antibody with different biological 
effector functions without changing antigen specificity (4). B cells 
also undergo somatic hypermutation (SHM). This inserts point-
mutations into Ig V region DNA, thereby providing the substrate 
for positive selection of antibody mutants with higher affinity 
to the antigen (6). Finally, B cells differentiate into plasma cells, 
which secrete large amounts of antibodies, or memory B cells, 
which can be re-activated for amnestic antibody responses upon 
second challenge by the same antigen (7–10). Memory B cells 
and plasma cells are long-lived and play an important role in the 
protection against re-exposure to microbial and other antigens.
B cell CSR/SHM and differentiation into plasma cells and 
memory B cells are tightly regulated. Dysregulation of these 
processes can lead to immune deficiencies, autoimmunity, or B 
lymphomagenesis. In this review, we will focus on how B cell 
differentiation is regulated for effective antibody responses by 
intracellular membranes, particularly the emerging functions 
of endosomes and autophagosomes. We will also emphasize the 
induction of proteins associated with these intracellular mem-
branes and the role of these proteins in signaling and induction 
of gene expression. Furthermore, we will summarize the evidence 
of the epigenetic modulation of expression of these proteins by 
microRNAs and the consequence to B cell differentiation – read-
ers are referred to other articles that have extensively reviewed the 
regulation/dysregulation of immune functions by microRNAs 
(11–15). Finally, we will discuss the notion that microRNA activi-
ties are reciprocally regulated by intracellular membranes, as part 
of the controlling mechanisms that fine-tune gene expression and 
buffer molecular aberrancies to ensure the specificity of B cell 
differentiation and functions.
B CeLL ReGULATiON BY 
iNTRACeLLULAR MeMBRANe-
ASSOCiATeD PROTeiNS
intracellular Membrane Structures and 
Associated Proteins
Endosomes are internalized lipid vesicles containing extracellular 
molecules and cell surface components, including fluid, solutes 
and their carriers, lipids, membrane proteins, and receptor–ligand 
complexes (16). They regulate various cellular processes by sort-
ing, processing, recycling, storing, and degrading these cargos. 
Early endosomes, which have tubular and vacuolar domains, are 
the main sorting station of internalized cargos, most of which 
are recycled back to the plasma membrane directly or through 
recycling endosomes (Figure  1). Late endosomes form from 
the vacuolar domains of early endosomes, with many changes 
in the lipid and protein contents. They mature upon moving 
from the peripheral cytoplasm to the perinuclear area, where 
mature late endosomes fuse with each other and eventually fuse 
with lysosomes or pre-existing hybrid organelle endolysosomes 
(Figure 1). Endosome maturation is regulated by a group of Rab 
(Ras-related in brain) small GTPases (17). Rab5 is a defining com-
ponent of early endosomes through various stages, and regulates 
the conversion of early endosomes to late endosomes (17). The 
GTP-bound form of Rab5 (Rab5-GTP) recruits Rab7 and is then 
converted to Rab5-GDP, which dissociates from the membrane 
(18, 19). Rab7, upon recruitment, can auto-activate to bind GTP 
and suppress Rab5 binding to GTP (20). Rab7-GTP recruits its 
own effectors, including RILP, which connects late endosomes 
to dynein motors for trafficking, and components of the HOPS 
complex, which promotes late endosome fusion with lysosomes 
(21, 22). Lysosomes are the terminal degradative compartments. 
These have a luminal pH of 4.6–5.0 and contain hydrolases that 
digest the cargo (17). They can also fuse with autophagosomes to 
form autolysosomes, which carries out degradation of extracel-
lular and intracellular components.
Macroautophagy (referred here as autophagy) is a process 
that degrades cytoplasmic compartments and organelles and is 
underpinned by the formation of autophagosomes, which are 
enclosed double-membrane structures (23). Autophagy was 
first characterized as a cellular process to counter stress, e.g., 
by mediating degradation of cytoplasmic organelles/proteins in 
starved cells for the generation of energy and macromolecules 
to maintain cell viability (24). Autophagosomes, however, can be 
induced under physiological stress-free conditions, likely through 
slightly different pathways, and play important roles in immunity 
(25, 26). Their induction starts from activation of a protein com-
plex containing ULK1 and the autophagy-related gene (Atg) 13, 
and formation of a phagophore, a double-membrane structure 
(Figure  1). The nucleation of phagophores requires activation 
of the class III phosphatidylinositol 3-kinase (PI-3K) complex 
consisting of the VPS34 (vacuolar protein sorting 34), which is 
activated by a complex containing Beclin 1, VPS15, and Atg14 
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(24). Phosphorylation of ULK1 and Atg13 by the mTOR kinase, 
which regulates B cell differentiation and CSR (27, 28), inhibits 
autophagy activation. Inhibition of mTOR, e.g., by rapamycin, 
promotes autophagosome formation (29). Autophagosomes 
form after the expansion and final closure of phagophores, and 
then fuse with either mature endosomes to form amphisomes or 
lysosomes to form autolysosomes, in which luminal cargos and 
the inner membrane are degraded (Figure 1) – amphisomes can 
also fuse with lysosomes to form autolysosomes.
Antigen Presentation
In T-dependent antibody responses, B cells uptake antigens 
through the BCR, process it, and present it through the major 
histocompatibility complex II (MHCII) to cognate CD4+ TH cell 
TCR to prime TH cells. These, in turn, will prime B cells for full 
activation, proliferation, and differentiation. It has been long 
known that antigen processing for MHC II-dependent presen-
tation is mediated by endosomes/lysosomes (30), while MHC 
I-dependent antigen presentation is mediated by endoplasmic 
reticulum (ER). Autophagy also plays an important role in MHC 
II-dependent antigen presentation in B cells and dendritic cells, in 
which autophagosomes continuously merge with multi-vesicular 
compartments loaded with MHC II (Figure 1). Targeting of the 
influenza virus matrix protein-1 to autophagosomes by fusion 
of this protein with LC3, a marker of growing autophagosomes, 
FiGURe 1 | Regulation of B cell differentiation and functions by intracellular membranes and associated proteins. Several B cell processes are regulated 
by endosomes, lysosomes, and autophagosomes. Upon antigen-triggered internalization, BCR is sorted by early endosomes to either recycle back onto the cell 
surface or go through antigen processing, which are mediated by endolysosomes, for the MHC II-dependent antigen presentation. Signaling receptors, such as 
CD40 (as depicted) and TLRs (both surface TLRs and intracellular TLRs), can be internalized and/or sorted by early endosomes to localize to mature late 
endosomes, as marked by Rab7. A Rab7-dependent process would stabilize the interaction of such receptors and their adaptors (e.g., CD40 and TRAF6), thereby 
promoting sustained signaling, such as NF-κB activation, for induction of genes important for B cell activation and CSR/SHM, e.g., AID. Lysosomes, as transformed 
from and maintained by mature late endosomes, can recruit mTOR, which plays an important role in B cell activation. Autophagosomes are important for memory B 
cell maintenance, i.e., through Atg7, and plasma cell differentiation and survival, e.g., through Atg5. They can also fuse with lysosomes to become autolysosomes, 
which then transform into a specialized compartment for antigen presentation.
strongly enhances the presentation of this protein to CD4+ T cells 
(31). Mice with conditional knockout (KO) of autophagosome-
associated protein Atg5 in dendritic cells fail to mount sufficient 
CD4+ T cell priming after herpes simplex virus infection (32). 
Conditional KO mice lacking Atg5 in B cells have not been ana-
lyzed in this context, but would likely display a similar phenotype.
Protein citrullination is highly relevant to rheumatoid arthritis 
(RA), as RA patients display high levels of autoantibodies to 
citrullinated self-proteins (33). Citrullinated peptides, but not 
unmodified peptides, are presented to T cells by dendritic cells 
and macrophages through autophagy. In B cells, citrullinated 
peptides are also presented in a manner dependent on BCR 
engagement (e.g., triggered by anti-IgM) and autophagosome 
formation (which can be blocked by 3-methyladenine, an inhibi-
tor of PI-3K and autophagy). Upon brief serum starvation, B 
lymphoma cells can also present citrullinated peptides through 
an Atg5- and autophagosome-dependent pathway (34).
B Cell Activation and CSR/SHM
Intracellular membrane-associated proteins regulate activation 
and differentiation of B cells, in addition to their development 
and survival – pre-B cell development in the bone marrow and 
B-1 cell survival in the periphery are defective in mice with B cell 
conditional KO (Cd19-cre) of Atg5 (35). Upon BCR engagement 
by antigen, the fast and extensive induction of autophagosomes, 
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in which the antigen would be rapidly processed, can cause cell 
death (36). Autophagy-dependent cell death can be overcome 
by CD40 engagement for full B cell activation (36), suggesting 
a role of autophagy in controlling self-reactive B cell activation 
and autoimmunity.
In B cells activated by CD40 engagement or dual TLR/BCR 
engagement (37), Rab7 is upregulated, suggesting a role of Rab7 
and Rab7+ late endosomes in peripheral antigen-dependent B 
cell differentiation. In conditional KO Igh+/Cγ1-creRab7fl/fl  mice, 
Rab7 is ablated only in B cells undergoing IghCγ1-cre Iγ1-Sγ1-Cγ1-
cre transcription, as induced  –  like Igh germline Iγ1-Sγ1-Cγ1 
transcription – by IL-4 in conjunction with CD40 or dual TLR/
BCR engagement (38). These mice are normal in B and T cell 
development, but cannot mount T-independent or T-dependent 
class-switched IgG1 responses, while maintaining normal IgM 
levels. Igh+/Cγ1-creRab7fl/fl B cells are normal in proliferation, 
survival, and plasma cell differentiation, as well as activation of 
the p38 kinase and ERK1/2 kinase pathways, but show defective 
CSR (38). This defect can be rescued by enforced expression of 
activation-induced cytidine deaminase (AID), which is essential 
for CSR and SHM. In addition, inhibition of Rab7 activity by a 
small molecule compound, CID 1067700 (39), reduces CSR and 
antibody responses in normal B cells/mice as well as autoanti-
body response and disease symptoms in lupus-prone MRL/Faslpr/
lpr mice (40). These findings, together with our demonstration 
that Rab7 mediates canonical NF-κB activation, as critical to AID 
induction, outline a novel role of Rab7 in signaling pathways that 
lead to AID expression and CSR, likely by promoting assembly 
of signaling complexes along mature endosomes. Such a role of 
Rab7 is consistent with the proximity of Rab7-containing mature 
late endosomes to the nucleus (Figure  1), as activated NF-κB 
would have a short path to reach genes, an advantage shared by 
ER membrane-mediated NF-κB activation, as occurring in BL41 
B cells upon CD40 engagement and in Jurkat T cells upon TCR 
engagement (41). It would also be irrespective of the initial loca-
tion of engaged immune receptors, e.g., on the plasma membrane 
(such as CD40, TLR1/2, and TLR4) or in endosomes (TLR7 and 
TLR9), and their trafficking pattern.
Lysosomes have been recently implicated to regulate signal 
transduction, serving as the “docking station” for mTOR in 
various cancer cells (42–44) and likely in B cells. Knock-in mice 
expressing a hypomorphic mTOR mutation and conditional KO 
mice with B cells mTOR deficiency are defective in germinal 
center formation and antibody responses, in concomitant with 
reduced AID expression and CSR (28). Pharmacological inhibi-
tion of mTOR kinase activity results in complicated phenotypes, 
likely due to non-redundant functions of two mTOR-containing 
complexes, mTORC1 and mTOC2 (28, 45).
Plasma Cell Differentiation
The differentiation of activated B cells into antibody-secreting 
plasma cells is associated with changes in gene expression that lead 
to the loss of the B cell identity and the gain of protein secretion 
functions. Such changes are mediated by the master transcription 
factor Blimp-1 (B lymphocyte-induced maturation protein-1), as 
encoded by Prdm1 (8). In plasma cells, ER membranes expand 
and enhance their capacity to fold nascent peptides, a process 
driven by X-box binding protein-1, to promote antibody secre-
tion (46). Both differentiating plasmablasts (which still prolifer-
ate) and terminally differentiated long-lived plasma cells have 
high autophagic activities. In two independently generated 
mouse strains with conditional Atg5 KO in B cells (both through 
Cd19-cre), antibody responses and generation of antigen-specific 
long-lived plasma cells are defective (47, 48), likely due to impair-
ment in generation of plasma cells (47), plasma cell survival 
(48), or both  –  the ER-related secretion function of plasma 
cells, however, does not seem to be affected (48). In addition, 
autophagosomes have been suggested to serve as a platform in 
recruiting ERK and its activation (49), which plays an important 
role in Blimp-1 induction and plasma cell differentiation (50). 
Rab7 does not play a major role in the generation of plasma cells, 
but may help in maintaining plasma cell survival, perhaps also 
through NF-κB-dependent sustained expression of Blimp-1 (40). 
Thus, intracellular-associated proteins are important for plasma 
cell homeostasis and sustainable antibody production.
Memory B Cell Differentiation
As recently shown, memory B cells specifically express high levels 
of autophagic activities and do so over time, i.e., low/no levels of 
autophagosome formation (LC3+ puncta) in naïve B cells, ger-
minal center B cells, and newly formed memory B cells, but high 
levels in memory B cells isolated much later after the primary 
immunization (51). Atgs, such as Ulk1, Atg14, Becn1 (encoding 
Beclin 1), Atg5, Atg7, and LC3, display similar expression pat-
terns. Furthermore, Atg7 is dispensable for the initial generation 
of memory B cells, but critical for the long-term survival of 
memory B cells, likely by preventing apoptosis, as mice with B 
cell conditional KO of Atg7 (through Cd19-cre) can mount nor-
mal primary antibody responses, but much reduced secondary 
antibody responses and SHM upon re-challenging by antigen 
(51, 52). Finally, memory B cells express high levels of a fork-
head family transcription factor FoxO3 and, to a lesser extent, 
FoxO1, consistent with the important role of these two factors in 
autophagy gene expression (53). How Atg7 and related intracel-
lular membranes regulate apoptosis and perhaps other metabolic 
processes for the maintenance of memory B cells remains to be 
determined. Overall, intracellular membranes play an important 
role in peripheral antigen-dependent B cell differentiation. And, 
different membrane structures, likely through their associated 
proteins, specify different differentiation processes, e.g., Rab7 
in CSR/SHM, Atg5 in plasma cell differentiation, and Atg7 in 
memory B cell differentiation (Figure 1).
ReGULATiON OF B CeLL 
DiFFeReNTiATiON BY iNTRACeLLULAR 
MeMBRANe-ASSOCiATeD PROTeiNS 
AND MicroRNAs
MicroRNAs Regulate Peripheral Antigen-
Dependent B Cell Differentiation
MicroRNAs are endogenous small non-coding RNAs that 
regulate adaptive and innate immunity, including B cell dif-
ferentiation (54, 55). They modulate gene expression through 
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mainly post-transcriptional mechanisms, such as inhibiting 
translation of mRNAs and/or promoting their degradation after 
pairing with the 3′-untranslated region (3′-UTR) of the target 
mRNA (Box 1). A single microRNA can regulate multiple gene 
targets and, conversely, a single gene can be regulated by multi-
ple microRNAs. Conditional KO of Dicer, which is essential for 
microRNA biogenesis, through Cd19-cre leads to impairment 
in the generation of follicular B cells with concomitant increase 
in marginal zone B cells (56). This, together with the higher 
Dicer expression in follicular B cells, supports the notion that 
selected microRNAs mediate this stage of B cell development. 
High titers of autoantibodies in female Dicer conditional KO 
mice suggest a role of microRNAs in preventing autoimmune 
diseases (56).
MicroRNAs regulate the germinal center reaction. As Aicda 
gene expression is restricted to B cells activated by T-independent 
or T-dependent stimuli, Aicda-cre mice have been widely used 
to generate activated B cell-specific KO of genes. Conditional 
KO of Dicer through Aicda-cre dampens germinal center forma-
tion, likely through elevated expression of Bim, a pro-apoptotic 
protein (57). Dicer KO B cells are also defective in proliferation 
and survival, leading to impairment in production of high-
affinity class-switched antibodies and generation of plasma cells 
or memory B cells. The relevant microRNAs missing in these 
KO B cells would include miR-155, as this microRNA is highly 
expressed in germinal center B cells and miR-155 KO leads to 
defective germinal centers (58, 59).
MicroRNAs play vital roles in CSR and SHM. MiR-155 
targets the Aicda 3′-UTR, as knock-in or transgenic mice 
with the miR-155-binding site mutated in Aicda 3′-UTR show 
higher level of AID expression with upregulation of CSR and 
SHM (60). MiR-181b can also target Aicda 3′-UTR to regulate 
AID expression and CSR. Accordingly, miR-181b expression is 
downregulated in activated B cells, thereby allowing accumula-
tion of AID (61). MiR-210 has been shown to be upregulated 
in activated B cells and inhibit CSR, likely by downregulating 
CSR factors  –  miR-210-deficient mice produce high levels of 
autoantibodies (62). B cell differentiation into plasma cells is 
also regulated by microRNAs. Overexpression of miR-125b, 
which is expressed in centroblasts (activated germinal center B 
cells that are enlarged and proliferating), represses plasma cell 
differentiation and Ig secretion by targeting Prdm1 (63). Finally, 
histone deacetylase inhibitors (HDI) upregulate miR-155, miR-
181b, and miR-361 to silence AICDA/Aicda, as well as miR-23b, 
miR-30a, and miR-125b to silence PRDM1/Prdm1 in human 
and mouse B cells (64), but not other CSR/SHM-related genes 
or microRNAs that are not known to regulate AICDA/Aicda or 
PRDM1/Prdm1 (65). Importantly, HDI also abolish CSR/SHM 
and impair the class-switched high-affinity antibody responses 
in normal mice and pathogenic autoantibody response in lupus-
prone mice (64).
MicroRNAs Regulate intracellular 
Membrane Functions
MicroRNAs regulate virtually all cellular pathways, including 
intracellular membrane functions, such as endocytosis (66), 
lysosome degradation (67), and autophagy (68). They would do 
so in cancer cells, stem cells, and B cells, which express relevant 
intracellular membrane structures. For instance, miR-509 can 
bind to the transcripts encoding Rab5C, one of the three Rab5 
isoforms, thereby inhibiting Rab5C expression in pre-B acute 
lymphoblastic leukemia cells and resulting in a growth defect 
that can be rescued by Rab5C overexpression (69). Targeting 
BOX 1 | MicroRNAs biogenesis and function.
MicroRNAs are a class of endogenous small non-coding RNAs, usually 19-23 nucleotide in length, that regulate gene expression through mainly post-transcriptional 
mechanisms. In microRNA biogenesis, a microRNA host gene is first transcribed by RNA polymerase II, giving rise to primary microRNA (pri-microRNA) transcripts. 
These are then processed by a complex composed of Drosha, an RNase III enzyme, and Pasha, a double-stranded RNA binding protein, to precursor microRNAs 
(pre-microRNAs), a stem-loop structure of 70-100 nucleotides. Pre-microRNAs are transported into the cytoplasm and cleaved by the Dicer RNase III. Resulting 
microRNA duplexes are incorporated into a RISC complex that also contains Ago. The “lead” functioning strand is guided to match the 3’-UTR of the mRNA target, 
while the “passenger” strand is degraded. A functional microRNA can pair perfectly or imperfectly with the microRNA recognition sites within mRNA 3’-UTR, leading 
to transcript degradation and translation inhibition, respectively.
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of SUMF1, a cellular sulfatase activator, by miR-95 disrupts 
sulfatase activities, resulting in an accumulation of sulfated sub-
strates in lysosomes that, in turn, impairs lysosome-mediated 
cargo degradation  –  miR-95-mediated lysosome dysfunction 
also results in defects in autophagy-mediated cargo degrada-
tion (67). Knocking down of miR-95 in cells isolated from 
patients with a severe lysosomal storage disorder called multiple 
sulfatase deficiency due to hypomorphic SUMF1 mutations 
can increase SUMF1 protein levels, suggesting a potential 
therapeutic intervention for this disease (67). MiR-376b directly 
targets the 3′UTR of ATG4C and BECN1 mRNA, thereby 
inhibiting Atg4C- and Beclin 1-dependent autophagy induced 
by starvation or rapamycin, and an antagomir of miR-376b 
increases Atg4C- and Beclin 1 expression and autophagy (70). 
Likewise, miR-20a and miR-106b suppresses ULK1 expression 
and autophagy, a process that can be de-repressed by nutrient 
(leucine) deprivation (71). Finally, systems biology approaches 
have led to the identification of several microRNAs (e.g., 
miR-130, miR-98, miR-124, miR-204, and miR-142) that can 
target lysosome-related proteins to modulate the autophagy– 
lysosomal pathways (72).
MicroRNAs Regulate intracellular 
Membrane-Associated Proteins involved 
in B Cell Differentiation
The miR-17–92 locus encodes a cluster of microRNAs (miR-17, 
miR-18a, miR-19a, miR-19b, miR-20a, and miR-92a) that play 
important roles in regulating immune functions (73). These 
microRNAs are essential for B cell development (74), but dis-
pensable for mature B cell survival (75). Mature B cell-specific 
miR-17-92 KO mice are defective in producing class-switching 
IgG2c antibodies (75). Lymphocyte-specific overexpression of 
miR-17-92 increases proliferation and survival of B cells and 
germinal center B cell differentiation, eventually leading to 
lymphomagenesis (76). Among microRNAs in the miR-17-92 
cluster, miR-17 targets transcripts encoding TBC1D2, which acts 
as a GTPase activating protein (GAP) of Rab7 to downregulates 
Rab7 activity (66)  –  TBC1D2 is also an effector of Rab7-GTP 
and would participate in the negative feedback-loop that con-
trols Rab7 activities. MiR-17-dependent upregulation of Rab7 
activities may explain, at least in part, the role of miR-17-92 in 
class-switched antibody responses. MiR-17 also targets Atg7 (77), 
suggesting a role of miR-17-92 in memory B cell differentiation, 
in addition to its inhibition of plasma cell homing to the bone 
marrow (75).
As we have recently reported (64), both miR-23b and miR-30a 
are upregulated by HDI in B cells to target the Prdm1 3′-UTR, 
thereby playing a role in mediating HDI repression of B cell 
differentiation into plasma cells (Figure 2). These microRNAs 
would also modulate plasma cell differentiation and/or functions 
by downregulating autophagic proteins, such as Atg5, Atg12, 
Beclin 1, and others factors (78–80) (Table 1). Another member 
of the miR-30 family, miR-30c, is predicted to target both Rab7 
and AID, consistent with the notion that one microRNA can 
target multiple factors in the same pathway to maximize its 
influence on the outcome of that pathway (Figure 2, a). Other 
examples supporting this notion include miR-302b, which can 
target IRAK4 and likely Rab7, both of which are important for 
TLR-induced NF-κB activation (38, 81). In addition, miR-155 
and miR-181b downregulate CSR by targeting AID. They may 
also inhibit plasma cell differentiation by virtue of their ability to 
target the 3′-UTR of transcripts encoding autophagic proteins, 
such as Atg5 and possibly Rheb and Rictor. MiR-93 targets the 
AICDA 3′-UTR and would regulate AID expression in activated 
B cells, as it does in the MCF7 breast cancer cell line (82), 
which, like several cancer cell lines, expresses elevated levels 
of AID, a potent DNA mutator and tumorigenesis factor (83). 
MiR-93 would also downregulate plasma cell differentiation 
by inhibiting autophagy and likely do so by targeting Atg16L1 
(82), SQSTM1 (84), and possibly a battery of other autophagic 
proteins, such as ULK1, ATG14 and RB1CC1 (Table 1). Finally, 
consistent with the notion that a single factor can be regulated by 
multiple microRNAs, Rab7 would be regulated by both miR-30c 
FiGURe 2 | Cross-regulation of intracellular membrane-associated proteins and microRNAs in B cell differentiation. (a) Regulation of multiple 
intracellular membrane-associated proteins as well as AID (critical for CSR/SHM) and Blimp-1 (driving plasma cell differentiation) by a single microRNA. For example, 
miR-30a regulates Atg5, Beclin 1 and Atg12 in autophagy and Blimp-1, miR-30c regulates Rab7 (in the endosome pathway) and AID, as well, miR-93 and 
miR-181b regulate AID as well as Atg16L1 and Atg5, respectively. (b) Regulation of one intracellular membrane-associated protein by several microRNAs. For 
example, Rab7 is regulated by both miR-30c and miR-302b, and Atg12 is regulated by both miR-30a and miR-23b. (c) Regulation of microRNA activities by 
endosomes and autophagosomes. Endosomes provide a structure to support the assembly of RISC in microRNA-mediated gene silencing. Autophagosomes 
promote degradation of Dicer and Ago, thereby downregulating microRNA biogenesis and functions, respectively.
TABLe 1 | MicroRNAs target intracellular membrane-associated proteins 
and factors critical for B cell differentiation and functions.
MicroRNAs intracellular 
membrane-
associated 
protein target
Specific 
factor 
target
Relevant B cell 
function
Reference
miR-17-92 TBC1D2, Atg7 Bim, 
Pten
B cell development, 
Germinal center 
reaction
(66, 73, 76, 
84)
miR-23b Atg12, Atg2Ba, 
RAB11FIP2a
Blimp-1 Plasma cell 
differentiation
(64, 85)
miR-30b Rab7a AIDa CSR (64, 79, 80)
Atg5, Beclin 1, 
Atg12a
Blimp-1 Plasma cell 
differentiation
miR-155 Rheb, Rictor AID CSR, SHM, 
Germinal center 
reaction
(60, 86, 87)
SHIP-1
miR-181b Atg5 AID CSR (61, 88)
miR-93 Atg16L1, 
SQSTM1, 
Atg14a, 
RB1CC1a, ULK1a
AID CSR (82, 84, 89)
miR-302b Rab7a, 
RABGAP1a, 
Rab9Aa
IRAK4 NF-κB activation (81)
miR-9 Atg14a, ULK2a NF-κB CSR (90)
miR-10a RB1CC1 BCL6 Germinal center 
reaction
(91, 92)
miR-146a SQSTM1a TRAF6 NF-κB activation (93)
aHigh confident targets predicted by miRDB (www.miRDB.org) (94).
bRab7 and AID are predicted to be targeted by miR-30c, with others being targets of 
miR-30a.
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and miR-302b (Figure 2, b), suggesting an (indirect) regulation 
of NF-κB induction and AID activation by these microRNAs.
As suggested by a recent study (95), intracellular membrane 
proteins would evade microRNA regulation by using mRNA 
transcripts with short 3′-UTRs for their production. Proteins can 
be encoded by mRNAs with alternative 3′-UTRs, the longer ones 
of which function as scaffold to interact with the RNA-binding 
proteins HuR and SET and facilitate the plasma membrane locali-
zation of membrane-associated proteins (95, 96) – HuR plays an 
important role in germinal center formation, CSR, and antibody 
responses, possibly though facilitating protein localization to 
the plasma membrane (97). When encoded by transcripts with 
shorter 3′-UTRs, which contain much fewer microRNA targeting 
sites and are less susceptible to microRNA-mediated silencing, 
these membrane-associated proteins would display a different 
subcellular localization, shifting from the plasma membrane to 
intracellular membrane structures.
Overall, the regulation of B cell differentiation and intracellular 
membrane-associated proteins by microRNAs would be deeply 
intertwined to achieve highly fine-tuned antibody responses.
CONCLUSiON AND PeRSPeCTiveS
Intracellular membrane structures regulate, in addition to cellular 
homeostasis and basic metabolic processes, B cell differentiation 
in antibody responses and likely other cell type-specific functions. 
Different intracellular membranes are responsible primarily for 
distinct B cell differentiation processes, such as Rab7+ mature late 
endosomes in AID induction and CSR/SHM, Atg5+ autophago-
somes in plasma cell differentiation and survival, and Atg7+ 
autophagosomes for memory B cell maintenance. Nevertheless, 
these lipid-containing micro-domains would also cross-talk, 
e.g., through their partially shared biogenesis pathways, thereby 
regulating multiple processes. Indeed, Rab7 would regulate 
plasma cell survival, in addition to its major role in CSR/SHM, 
and the collaboration of different membranes in regulating B 
cell differentiation is suggested by the role of ER in endosome 
biogenesis (98).
Specific functions of selected intracellular membrane-associ-
ated proteins would reflect their induction in differentiating B 
cells, as epitomized by the upregulation of Rab7 in activated B 
cells and elevated levels of Atg7 as memory B cells survive over 
the time. This notion emphasizes the importance of the profiling 
of expression of intracellular membrane-associated proteins and 
biogenesis of intracellular membrane structures in B cells toward 
our full understanding of B cell differentiation fate decision. As 
such, a comprehensive analysis of the role of intracellular mem-
branes in signal transduction, which is ultimately responsible 
for gene regulation, is intriguing, as it would not only support 
the emerging paradigm that membrane organization specifies 
the signal output, but also reveal feedback-loop regulation 
mechanisms that contribute to the tight regulation of B cell 
differentiation.
As suggested by the critical dependence of endosomes on 
Rab5 expression levels (99), intracellular membranes are sensitive 
for their maintenance to the depletion of relevant factors, making 
microRNA, powerful regulators of intracellular membrane func-
tions and, therefore, B cell differentiation. Interestingly, intracel-
lular membranes would regulate B cell differentiation in part by 
modulating microRNA activities, as suggested by an important 
role of endosomes in promoting formation of an RNA-induced 
silencing complex (RISC) and downregulation of Dicer and Ago 
by autophagy (Figure 2, c). Ago2, a component of RISC, localizes 
to mature endosomes and RISC-bound mRNAs accumulate in 
GW bodies, which are discrete cytoplasmic foci associated with 
mature endosomes (100). Blocking endosomes maturation (by 
deletion of ESCRT complexes) results in loss of GW bodies and 
impairment in microRNA-mediated gene silencing, while accu-
mulation of mature endosomes (through depletion of a tethering 
factor HPS4) enhances microRNA-mediated silencing (101, 102), 
all pointing to a positive role of endosomes in microRNA func-
tions. By contrast, the autophagic pathway degrades Dicer and 
Ago that are not bound with any pre-microRNA and microRNA, 
respectively, in a manner dependent on the autophagy receptor 
NDP2, which interacts with LC3 (103). Dicer accumulates in 
cells deficient of the critical autophagy components Atg5, Atg6, 
or Atg7 (104), suggesting that B cell-specific conditional KO of 
Atg5 and Atg7 may display elevated levels of microRNAs that 
would, in turn, downregulate factors important for plasma cell 
differentiation (e.g., Blimp-1) and memory B cell maintenance.
Collectively, intracellular membrane structures and microR-
NAs would regulate important B cell processes. The reciprocal 
regulation of intracellular membranes and microRNAs would 
fine-tune at any time the gene expression necessary to achieve 
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